Wednesday, February 19, 2014

Presented by:
Max S. Wicha, MD

Distinguished Professor, Medical Oncology,
University of Michigan, Ann Arbor
Professor, Department of Internal Medicine,
University of Michigan, Ann Arbor
Founding Director, University of Michigan
Comprehensive Cancer Center

Recent evidence has indicated that many cancers, including breast cancer, are driven by a sub-population
of cells that display stem cell properties. These cancer stem cells mediate tumor metastasis and by virtue of
their relative resistance to chemotherapy and radiation therapy may be responsible for tumor recurrence. This
suggests that improvements in cancer therapy may require targeting the cancer stem cell population. A
number of clinical trials designed to target cancer stem cells are in progress and will determine whether
this approach included patient outcome.

Loading more stuff…

Hmm…it looks like things are taking a while to load. Try again?

Loading videos…